代谢因素调控糖尿病与肺功能改变的关联
研究基于德国糖尿病研究(GDS)中1型糖尿病426例、2型糖尿病482例及糖耐量正常对照244例的横断面肺功能数据,结合孟德尔随机化分析,发现胰岛素抵抗、胰岛素清除受损及较高胰岛素剂量与FEV1和FVC降低相关,提示高胰岛素血症可能是糖尿病相关肺功能损害的致病机制。
要点
- 胰岛素敏感性(M值)和胰岛素清除率越高,FEV1和FVC越高。
- 2型糖尿病较1型和对照FEV1和FVC更低,且与M值相关。
- 孟德尔随机化支持HOMA-IR与较低FEV1存在因果关联。
核心结论
- 糖尿病中较低的FEV1和FVC与胰岛素抵抗、清除受损及较高胰岛素剂量相关,导致高胰岛素血症,可能是潜在致病机制。
研究设计与样本
- 德国糖尿病研究(GDS)横断面分析,纳入1型糖尿病426例、2型糖尿病482例和糖耐量正常对照244例的肺量计测量,并采用Botnia钳夹评估胰岛素敏感性、分泌和清除。
- 孟德尔随机化分析使用MAGIC联盟HOMA-IR数据(n=37,037)和UK Household Longitudinal Study肺功能数据(n=321,047)。
主要发现
- 在GDS中,较高的M值(所有β>0.18,P<0.0001)和胰岛素清除率(所有β=0.05,P<0.050)与较高的FEV1和FVC相关。
- 与1型糖尿病和对照相比,2型糖尿病FEV1和FVC较低,且与M值相关(所有β>0.17,P<0.050)。
- 1型糖尿病中FEV1与每日胰岛素剂量相关(β=-0.21,P=0.0006)。
- FEV1与2型糖尿病(β=-0.19,P=0.0052)、严重胰岛素抵抗型(β=-0.27,P=0.039)和轻度年龄相关糖尿病(β=-0.23,P=0.0033)相关。
- 孟德尔随机化支持HOMA-IR与较低FEV1的因果关联(β=-0.13,P=0.0018)。
临床怎么用
- 对糖尿病患者评估肺功能时,应关注胰岛素抵抗、胰岛素清除率和胰岛素剂量等代谢因素。
- 高胰岛素血症可能是糖尿病相关肺功能损害的干预靶点,需进一步研究验证。
局限性
- GDS部分为横断面分析,无法完全确定因果关系。
- 孟德尔随机化分析基于独立队列,但未在原文中报告具体局限性细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Type 1 and 2 diabetes have been variably associated with reduced forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), but mechanisms remain unclear. This study examined the role of glucose and insulin metabolism for pulmonary function across diabetes (sub)types and normal glucose tolerance as the control (CON) in the German Diabetes Study (GDS) and assessed causality by Mendelian randomization (MR) analyses in independent cohorts. RESEARCH DESIGN AND METHODS: In GDS, 426 spirometry measurements of participants with type 1 diabetes, 482 of participants with type 2 diabetes, and 244 of CON were cross-sectionally analyzed after phenotyping, including Botnia clamps for insulin sensitivity (M value), secretion, and clearance. Associations between metabolic measures and lung function were assessed using generalized linear models, adjusting for confounders. MR analysis used data from the MAGIC (Meta-Analyses of Glucose and Insulin-Related Traits Consortium) consortium (HOMA-insulin resistance [IR], n = 37,037) and the UK Household Longitudinal Study (pulmonary function, n = 321,047). RESULTS: In GDS, higher M value (all β > 0.18, P < 0.0001) and insulin clearance (all β = 0.05, P < 0.050) were associated with higher FEV1 and FVC. Compared with type 1 diabetes and CON, type 2 diabetes had lower FEV1 and FVC, which associated with M value (all β > 0.17, P < 0.050). FEV1 was associated with daily insulin doses in type 1 diabetes (β = -0.21, P = 0.0006). FEV1 was associated with type 2 diabetes (β = -0.19, P = 0.0052), severe insulin resistant (β = -0.27, P = 0.039), and mild age-related diabetes (β = -0.23, P = 0.0033). MR supported a causal association between HOMA-IR and lower FEV1 (β = -0.13, P = 0.0018). CONCLUSIONS: Lower FEV1 and FVC in diabetes are linked to insulin resistance, impaired clearance, and higher insulin doses, all of which result in higher insulinemia and likely represent underlying pathogenic mechanisms.
引用
- Di Marco M, Bódis KB, Li Z, et al. Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations. Diabetes Care. 2026. PMID: 41474454. doi:10.2337/dc25-2334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。